Infliximab-abda offers similar benefits at lower costs
More accurate than existing noninvasive tests
A cost-effective alternative to enoxaparin?
Results of the largest population-based study to date
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy